Skip to main content
QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
39.09
-0.01 (-0.03%)
Nov 4, 2024, 4:00 PM EST - Market closed

QuidelOrtho Revenue

QuidelOrtho had revenue of $637.00M in the quarter ending June 30, 2024, a decrease of -4.22%. This brings the company's revenue in the last twelve months to $2.83B, down -10.34% year-over-year. In the year 2023, QuidelOrtho had annual revenue of $3.00B, down -8.21%.

Revenue (ttm)
$2.83B
Revenue Growth
-10.34%
P/S Ratio
0.92
Revenue / Employee
$399,239
Employees
7,100
Market Cap
2.63B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.00B-268.20M-8.21%
Jan 1, 20233.27B1.57B92.28%
Jan 2, 20221.70B36.90M2.22%
Jan 3, 20211.66B1.13B210.66%
Dec 31, 2019534.89M12.61M2.41%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Amneal Pharmaceuticals 2.60B
Evolent Health 2.35B
Astrana Health 1.59B
LifeStance Health Group 1.16B
Catalyst Pharmaceuticals 434.48M
TransMedics Group 401.09M
Veracyte 399.58M
Protagonist Therapeutics 319.12M
Revenue Rankings

QDEL News

More News